Investigative Ophthalmology & Visual Science, Vol 37, 2519-2526, Copyright © 1996 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Retinal control on the axial length mediated by transforming growth factor-beta in chick eye

S Honda, S Fujii, Y Sekiya and M Yamamoto
Department of Ophthalmology, Kobe University School of Medicine, Japan.

PURPOSE: To clarify retinal control on scleral growth in form- deprivation myopia (FDM) in the chick, the authors studied change in transforming growth factor-beta (TGF-beta) in the form-deprived eye and the effect of this growth factor on scleral cell proliferation and axial length. METHODS: Change in TGF-beta in FDM in the chick was measured by reverse transcriptase polymerase chain reaction (RT-PCR), immunoblot, and immunohistochemistry. The effect of TGF-beta on [3H]thymidine uptake of scleral chondrocytes was determined by organ culture. Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor-1 (PAI-1) were administered to determine the effect of TGF-beta activation on the axial length in normal and FDM eyes. RESULTS: The content of TGF-beta messenger RNA (mRNA) and the active form of TGF-beta protein were reduced in FDM eyes compared with the control specimen. Reduced immunoreactivity of TGF-beta in FDM eyes was found in the photoreceptor layer. The TGF-beta inhibited [3H]thymidine uptake into scleral chondrocytes. In the nondeprived eyes, the vitreous chamber depth and axial length were reduced after uPA treatment, whereas PAI-1 increased them. In the form-deprived eyes, uPA inhibited vitreous depth and axial length elongation, but PAI-1 had no effect. CONCLUSIONS: The authors' results suggest that TGF-beta mediates retinal control of ocular growth. Axial elongation in FDM probably is correlated with the reduction of TGF-beta in the retina, retinal pigment epithelium, and choroid. The uPA and PAI-1 treatment controls the activation of TGF-beta and affects axial length.

This article has been cited by other articles:

				K. K. Pertile, M. Schache, F. M. A. Islam, C. Y. Chen, M. Dirani, P. Mitchell, and P. N. Baird Assessment of TGIF as a Candidate Gene for Myopia Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 49 - 54. [Abstract] [Full Text] [PDF]

				R. Schippert, E. Burkhardt, M. Feldkaemper, and F. Schaeffel Relative Axial Myopia in Egr-1 (ZENK) Knockout Mice Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 11 - 17. [Abstract] [Full Text] [PDF]

				E. Bertrand, C. Fritsch, S. Diether, G. Lambrou, D. Muller, F. Schaeffel, P. Schindler, K. L. Schmid, J. van Oostrum, and H. Voshol Identification of Apolipoprotein A-I as a "STOP" Signal for Myopia Mol. Cell. Proteomics, November 1, 2006; 5(11): 2158 - 2166. [Abstract] [Full Text] [PDF]

				J. Zhou, E. F. Rappaport, J. W. Tobias, and T. L. Young Differential Gene Expression in Mouse Sclera during Ocular Development Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1794 - 1802. [Abstract] [Full Text] [PDF]

				A. I. Jobling, M. Nguyen, A. Gentle, and N. A. McBrien Isoform-specific Changes in Scleral Transforming Growth Factor-{beta} Expression and the Regulation of Collagen Synthesis during Myopia Progression J. Biol. Chem., April 30, 2004; 279(18): 18121 - 18126. [Abstract] [Full Text] [PDF]

				S. Fujii, M. F. T. Escaño, K. Ishibashi, M. Fujii, Y. Sekiya, M. Yamamoto, and K. Saijoh Differential Expression of Neuroendocrine-Specific Protein in Form-Deprived Chick Eyes Invest. Ophthalmol. Vis. Sci., May 1, 2000; 41(6): 1533 - 1541. [Abstract] [Full Text]

				J. A. Rada, C. A. Perry, M. L. Slover, and V. R. Achen Gelatinase A and TIMP-2 Expression in the Fibrous Sclera of Myopic and Recovering Chick Eyes Invest. Ophthalmol. Vis. Sci., December 1, 1999; 40(13): 3091 - 3099. [Abstract] [Full Text] [PDF]